---
$id: https://graph.org.ai/products/commodity/51372016
$type: Product
source: UNSPSC
code: "51372016"
title: "Nalbuphine"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nalbuphine

**UNSPSC Code**: 51372016
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2T84IQI2K. European Medicines Agency schedules Nalbuphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09137MIG. Nalbuphine generally arises in the molecular formula C21H27NO4. The term NALBUPHINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, no. 10 1969, list 9.) NALBUPHINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nalbuphine under HS 29391900 and SITC 54141. As of Q4 2014, NALBUPHINE remains the US FDA Preferred Term for this commodity. Nalbuphine bears US NLM identifiers UMLS ID C0027348 and NCI Concept Code C61854. SMILES: O1C2C34C(O)(C(N(CC3)CC3CCC3)CC3C4C1C(O)CC3)CCC2O.

